Media Centre

Featured Media Release
 

23 May 2014 - Skin Science Facility to Close in Rowville, Victoria

GSK announced today the immediate closure of the Stiefel, skin science facility in Rowville, Victoria.

 
 

Media Releases


Sydney manufacturing operations to change

GlaxoSmithKline (GSK) Australia announced today that the manufacture of toothpaste products will cease in Australia, Sydney by December 2011.

24/11/2010

 

GSK Australia Avandia Update

GlaxoSmithKline (GSK) continues to believe that Avandia is an important treatment option for patients with type 2 diabetes, and is not aware of any legal proceedings having been initiated in Australia in respect of Avandia.

22/10/2010

 

Avandia (rosiglitazone maleate) - Australian Update

Following a review of Avandia® (rosiglitazone maleate) by the European Medicines Agency (EMA) and the US Food and Drug Administration], each agency has today informed GlaxoSmithKline (GSK) of their individual regulatory decisions and resulting...

24/09/2010

 

Avandia (rosiglitazone maleate): GSK Australia spokesperson available post FDA Advisory Group Recommendation.

GlaxoSmithKline (GSK) Australia Medical Director, Dr Camilla Chong will be available to speak with Australian journalists about the outcome of the U.S. Food and Drug Administration (FDA) Advisory Committee recommendation in relation to the...

13/07/2010

 

ViiV Healthcare Lauched in Australia

New specialist HIV company dedicated to delivering advances in HIV treatment and care

04/11/2009

 

GlaxoSmithKline Completes Acquisition of Stiefel

GlaxoSmithKline plc (GSK) announced that it has completed its acquisition of Stiefel

24/07/2009

< 4 5 6 7 8 9 10 11 12 13 14